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Abstract Influenza A viruses (IAV) are subject to species barriers that prevent frequent zoonotic
transmission and pandemics. One of these barriers is the poor activity of avian IAV polymerases in
human cells. Differences between avian and mammalian ANP32 proteins underlie this host range
barrier. Human ANP32A and ANP32B homologues both support function of human-adapted
influenza polymerase but do not support efficient activity of avian IAV polymerase which requires
avian ANP32A. We show here that the gene currently designated as avian ANP32B is evolutionarily
distinct from mammalian ANP32B, and that chicken ANP32B does not support IAV polymerase
activity even of human-adapted viruses. Consequently, IAV relies solely on chicken ANP32A to
support its replication in chicken cells. Amino acids 129I and 130N, accounted for the inactivity of
chicken ANP32B. Transfer of these residues to chicken ANP32A abolished support of IAV
polymerase. Understanding ANP32 function will help develop antiviral strategies and aid the design
of influenza virus resilient genome edited chickens.
DOI: https://doi.org/10.7554/eLife.45066.001
Introduction
Influenza A viruses (IAV) infect a wide range of host species but originate from wild birds. Zoonotic
transmission from the avian reservoir is initially restricted by host specific species barriers. Infection
of new host species requires the virus to bind to cell surface receptors, utilise foreign host cellular
proteins whilst evading host restriction factors in order to replicate its genome, and finally transmit
between individuals of the new host.
The negative sense RNA genome of influenza A virus (IAV) is replicated in the cell nucleus using a
virally encoded RNA-dependent RNA polymerase, a heterotrimer composed of the polymerase basic
1 (PB1), polymerase basic 2 (PB2) and polymerase acidic (PA) proteins together with nucleoprotein
(NP) that surrounds the viral RNA, forming the viral ribonucleoprotein complex (vRNP) (Te Velthuis
and Fodor, 2016).
Crucially, the viral polymerase must co-opt host factors to carry out transcription and replication
(Te Velthuis and Fodor, 2016). The PB2 subunit is a major determinant of the host restriction of the
viral polymerase (Almond, 1977). Avian IAV polymerases typically contain a glutamic acid at position
627 of PB2, and mutation to a lysine, the typical residue at this position in mammalian-adapted PB2
(Subbarao et al., 1993), can adapt the avian polymerase to function efficiently in mammalian cells.
We have suggested that the restriction of avian IAV polymerase is due to a species specific differ-
ence in host protein ANP32A (Long et al., 2016). Avian ANP32A proteins have a 33 amino acid
insertion, lacking in mammals, and overexpression of chicken ANP32A (chANP32A) in human cells
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rescues efficient function of avian origin IAV polymerases (Long et al., 2016). Removal of the 33
amino acids from chANP32A prevents polymerase rescue, whilst conversely artificial insertion of the
33 amino acids into either huANP32A or B overcomes host restriction (Long et al., 2016). A naturally
occurring splice variant of avian ANP32A lacks the first four amino acids of the 33 amino acid inser-
tion, reducing the rescue efficiency of avian IAV polymerase in human cells (Baker et al., 2018). This
may be due to the disruption of a SUMOylation interaction motif, shown to enhance chANP32A’s
interaction with IAV polymerase (Domingues and Hale, 2017). In human cells, both family members
ANP32A and ANP32B (huANP32A/B) are utilised by human adapted IAV polymerases, and are
thought to stimulate genome replication from the viral cRNA template, although the exact mecha-
nism remains unclear (Sugiyama et al., 2015).
Here we demonstrate that the avian ANP32B clade is evolutionarily distinct from mammalian and
other ANP32Bs. We demonstrate that two amino acids differences, N129 and D130, in the LRR5
domain of chANP32B render it unable to interact with and support IAV polymerase function. We
used CRISPR/Cas9 to remove the exon encoding the 33 amino acid insertion from chANP32A or to
knockout the entire protein in chicken cells. Edited cells that expressed the short chANP32A isoform
lacking the additional 33 amino acids supported mammalian-adapted but not avian IAV polymerase
activity. Cells completely lacking chANP32A did not support either mammalian or avian IAV poly-
merase activity and were resilient to IAV infection. These results suggest a strategy to engineer IAV
resilience in poultry through genetic deletion or amino acid changes of the LRR domain of ANP32A
protein.
Results
Phylogenetic analysis identifies that avian ANP32B is a paralog of
mammalian ANP32B
To examine the relatedness of ANP32 proteins from different species, we constructed a phyloge-
netic tree using vertebrate ANP32 protein sequences using Drosophila mapmodulin protein as an
outgroup. ANP32A and E homologues formed well-supported monophyletic clades which included
multiple avian and mammalian species (Figure 1, Figure 1—figure supplement 1). Most vertebrate
eLife digest The influenza A virus pandemic of 1918 killed more people than the armed
conflicts of World War 1. Like all other pandemic and seasonal influenza, this virus originated from
bird viruses. In fact, avian influenza viruses continually threaten to spark new outbreaks in humans,
but pandemics do not occur often. This is because these viruses must undergo several adaptations
before they can replicate in and spread between people.
Viruses make new copies of themselves using the molecular machinery of the cells that they
invade. The proteins that make up this machinery are often slightly different in different species, and
so a virus that can replicate in cells of one species might not be able to do so when it invades a cell
from another species. In 2016, researchers discovered that species differences in a cell protein called
ANP32A pose a key barrier that avian influenza viruses have to overcome.
Now, Long et al. – including some of the researchers involved in the 2016 study – show that the
avian influenza virus cannot replicate in chicken cells that lack ANP32A. Exploring closely related
versions of the genes that produce ANP32A and its relative ANP32B in different species revealed
the region of the protein that the virus relies on to support its replication. Long et al. speculate that
by making a few small changes to the ANP32A gene in chickens, it might be possible to generate a
gene-edited chicken that is resilient to influenza.
Close contact with poultry has led to hundreds of cases of ‘bird ‘flu’ in South East Asia, many of
which have been fatal. Moreover, if avian influenza viruses mutate further in an infected person, a
new pandemic could begin. Stopping influenza viruses from replicating in chickens would prevent
people from being exposed to these dangerous viruses, whilst also improving the welfare of the
chickens.
DOI: https://doi.org/10.7554/eLife.45066.002
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ANP32B proteins formed a monophyletic clade but this clade did not include avian ANP32B pro-
teins. Rather, avian ANP32B proteins were strongly supported as members of a distinct clade with
ANP32C from Xenopus and unnamed predicted proteins from non-placental mammals. This sug-
gests that avian ANP32B and mammalian ANP32B are paralogues: birds have lost the protein orthol-
ogous to human ANP32B and eutherian mammals have lost the protein orthologous to avian
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Figure 1. Phylogenetic and sequence analysis reveals avian ANP32B to be a paralog of mammalian ANP32B. The best maximum-likelihood tree was
calculated from a set of ANP32 proteins with mapmodulin from Drosophila melanogaster as an outgroup using RAxML with 100 bootstraps. This figure
is a cladogram showing the relationships between mammalian ANP32s, avian ANP32s and ANP32s from Xenopus tropicalis. Selected bootstrap values
show the relationship between different ANP32 protein clades. Avian ANP32B clade is shown in green. The full tree is shown in Figure 1—figure
supplement 1.
DOI: https://doi.org/10.7554/eLife.45066.003
The following figure supplements are available for figure 1:
Figure supplement 1. Phylogenetic and sequence analysis reveals avian ANP32B to be a paralog of mammalian ANP32B.
DOI: https://doi.org/10.7554/eLife.45066.004
Figure supplement 2. Synteny of ANP32 genes.
DOI: https://doi.org/10.7554/eLife.45066.005
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ANP32B. Synteny provides further evidence to support the evolutionary relationship between avian
ANP32B, Xenopus ANP32C, and the unnamed marsupial gene as they are all found adjacent to
ZNF414 and MYO1F on their respective chromosomes (Figure 1—figure supplement 2). In humans,
we found a short stretch of sequence between ZNF414 and MY01F which appears homologous to
avian ANP32B (Figure 1—figure supplement 2). This provides further evidence that a functional
gene orthologous to avian ANP32B has been lost in placental mammals.
Chicken ANP32B does not support IAV polymerase activity
We and others have previously shown that both human ANP32A and B proteins support activity of a
human-adapted IAV polymerase in human cells (Long et al., 2016; Sugiyama et al., 2015;
Watanabe et al., 2014). Using CRISPR/Cas9, we generated human eHAP1 cells that lacked expres-
sion of both human ANP32A and ANP32B protein (Staller et al. in review). In WT eHAP1 cells,
human-adapted IAV polymerase (PB2 627K), derived from an H5N1 virus A/turkey/England/50-92/
1991 (50-92), was active, whereas the WT avian polymerase (PB2 627E) was not. Exogenous expres-
sion of C-terminally FLAG-tagged chANP32A could rescue the activity of avian IAV polymerase
whereas expression of chANP32B-FLAG, which naturally lacks the 33 amino acid insertion, did not
(Figure 2a). In double knockout cells, neither human-adapted nor avian-origin polymerase were
active. Expression of chANP32A-FLAG rescued activity of both polymerases but expression of
chicken ANP32B-FLAG rescued neither, despite confirmation of robust expression by western blot
(Figure 2b and c). This suggests that chicken ANP32B is not functional for IAV polymerase and that
the IAV polymerase activity relies on ANP32A in chicken cells. To confirm this in chicken cells, we
used CRISPR/Cas9 gene editing to generate chicken DF-1 cells which lacked chANP32B but retained
chANP32A expression (Figure 2—figure supplement 1). Wild type DF-1 cells had mRNAs for
chANP32A, B and E (Figure 2—figure supplement 1) and supported activity of avian IAV polymer-
ase bearing either PB2 627E or 627K. Overexpression of chANP32B-FLAG did not affect activity
(Figure 2d). DF-1 bKO cells also supported activity of both polymerases and again, exogenous
expression of chANP32B had no effect. Since chicken cells lacking expression of chANP32B did not
demonstrate any loss of IAV polymerase activity compared to WT, this implied that chANP32B is not
functional for IAV polymerase and that IAV polymerase uses solely ANP32 family member A in
chicken cells.
Chicken cells lacking intact ANP32A do not support avian IAV
polymerase activity
To investigate the function of ANP32A in chicken cells we utilised a cell type that is more amenable
to genome editing and clonal growth. Primordial germ cells (PGCs) are the lineage restricted stem
cells which form the gametes in the adult animal. PGCs from the chicken embryo can be easily iso-
lated and cultured indefinitely in defined medium conditions (van de Lavoir et al., 2006;
Whyte et al., 2015). Chicken PGCs can be edited using artificial sequence-specific nucleases and
subsequently used to generate genome edited offspring (Park et al., 2014; Oishi et al., 2016).
Under appropriate in vitro conditions PGCs can acquire pluripotency and be subsequently differenti-
ated into multiple cell types (Matsui et al., 1992; Shim et al., 1997; Shamblott et al., 1998;
Park and Han, 2000). Chicken PGC cells were genome edited using CRISPR/Cas9 and a single
guide RNA which generated chANP32A knock-out cells (aKO) containing a biallelic deletion of 8
nucleotides in exon 1. PGCs lacking the 33 amino acid insertion in chANP32A were generated using
a pair of guide RNAs to remove exon five resulting in chicken cells with a mammalian-like ANP32A
(D33) (Figure 3a). The precise deletions were confirmed by Sanger sequence analysis of subcloned
PCR products from genomic DNA, and both found to be homozygous at both alleles (Figure 3—fig-
ure supplement 1). We differentiated the edited chicken PGCs into fibroblast-like cells using serum
induction with the aim of generating cell lines to test avian IAV polymerase activity (Figure 3—figure
supplement 2). The predicted alterations of ANP32A protein in these cells were confirmed by west-
ern blot analysis of the PGC-derived fibroblast cells (Figure 3b). WT, D33, and aKO and PGC-
derived cell lines were tested for the functional effects of alteration or loss of chANP32A expression
on IAV polymerase activity measured by reconstituted minigenome assay. Both avian (PB2 627E) and
human-adapted polymerase (PB2 627K) were active in WT fibroblast cells (Figure 3c). Removal of
the 33 amino acids from ANP32A resulted in restriction of the 627E polymerase but not the 627K
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polymerase, mirroring the avian IAV polymerase phenotype observed in mammalian cells
(Long et al., 2016). Both polymerases were restricted in cells lacking chANP32A (aKO). Expression
of exogenous chANP32A in D33 and aKO cells rescued avian IAV polymerase activity (Figure 3d &
e) demonstrating the specificity of the genetic alterations. The lack of polymerase activity in the aKO
PGC cell line supports the hypothesis that, in the absence of chANP32A, the remaining ANP family
members including chANP32B or chANP32E could not support IAV polymerase activity in chicken
cells, even though ANP32B and E mRNAs were readily detected in both DF-1 and PGC cells (Fig-
ure 2—figure supplement 1 and Figure 3—figure supplement 1).
Figure 2. Chicken ANP32B is not functional for IAV polymerase. Cells were transfected with avian H5N1 50–92 polymerase (PB2 627E or 627K) together
with NP, firefly minigenome reporter, Renilla expression control, either Empty vector (control) or ANP32 expression plasmid and incubated at 37˚C for
24 hr. (a) Minigenome assay in human eHAP1 cells with co-expressed Empty vector, FLAG-tagged chANP32A or chANP32B. (b) Minigenome assay in
double knockout (dKO) eHAP1 cells. (c) Western blot analysis of dKO eHAP1 cell minigenome assay confirming expression of PB2 and FLAG-tagged
chANP32A and B. (d) Minigenome assay in WT DF-1 cells with either co-expressed Empty vector or chANP32B. (e) Minigenome assay in DF-1 ANP32B
knockout (bKO) cells with either co-expressed Empty vector or chANP32B. Data shown are firefly activity normalised to Renilla, plotted as mean ± SEM
(n = 3 biological replicates). Two-way ANOVA with Dunnet’s multiple comparisons to Empty vector. ns = not significant, ****p<0.0001.
DOI: https://doi.org/10.7554/eLife.45066.006
The following figure supplement is available for figure 2:
Figure supplement 1. Sequence analysis of ANP32 in genome edited DF-1 chicken cells.
DOI: https://doi.org/10.7554/eLife.45066.007
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Figure 3. Chicken PGC derived fibroblast cells lacking ANP32A or the 33 amino acid insertion do not support
avian IAV polymerase activity. (a) Schematic of CRISPR/Cas9 RNA guide targets used to generate aKO (exon1)
and D33 (exon 5) PGC cell lines. (b) Western blot analysis of ANP32A and b-actin expression in WT, KO and D33
PGC-derived fibroblast cells. (c) Minigenome assay in WT, D33 or aKO PGC derived fibroblast cells with either
PB2627E (black) or 627K (grey) polymerase derived from avian H5N1 50–92 virus. (d) Minigenome assay in WT, D33
or aKO cells with avian H5N1 50–92 PB2 627E polymerase co-transfected with Empty vector (black) or FLAG-
tagged chANP32A (grey). (e) Western blot analysis of PB2, FLAG and Histone 3. Data shown are firefly activity
normalised to Renilla, plotted as mean ± SEM (n = 3 biological replicates). Two-way ANOVA with Dunnet’s
multiple comparisons to WT. ns = not significant, **p<0.01, ***p<0.001, ****p<0.0001.
DOI: https://doi.org/10.7554/eLife.45066.008
The following figure supplements are available for figure 3:
Figure supplement 1. Sequence analysis of ANP32 in genome edited PGC chicken cells.
DOI: https://doi.org/10.7554/eLife.45066.009
Figure supplement 2. In vitro reprogramming of chicken PGCs into adherent fibroblast-like cells.
DOI: https://doi.org/10.7554/eLife.45066.010
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Functional differences between chicken ANP32A and ANP32B map to
the LRR domain sequence
ANP32 proteins share a common domain organisation in which an N terminal domain consisting of 5
consecutive leucine rich repeats (LRR 1–5) is followed by a cap and central domain and a C terminal
low complexity acidic region (LCAR). In avian ANP32A proteins (except some flightless birds) a
sequence duplication, derived in part from nucleotides that encode 27 amino acids (149-175), has
resulted in an additional exon and an insertion of up to 33 amino acids between the central domain
and the LCAR (Figure 4a). We previously showed that insertion of the 33 amino acids from the cen-
tral domain of chANP32A into the equivalent region of the human ANP32A or huANP32B proteins
conferred the ability to rescue the activity of a restricted avian IAV polymerase in human cells. The
equivalent 33 amino acid insertion into chANP32B (chANP32B33) did not support avian IAV polymer-
ase activity (Figure 4b). In order to ascertain the domains of chANP32B that rendered it non-func-
tional for IAV polymerase activity, we generated chimeric constructs between human and chicken
ANP32B. To measure the rescue of avian IAV polymerase in human 293 T cells, all chimeric con-
structs had the 33 amino acid sequence derived from chANP32A inserted between the LRR and
LCAR domains. Western blot analysis and immunofluorescence confirmed that all chimeric constructs
were expressed and localised to the cell nucleus as for the wild type ANP32 proteins. (Figure 4b
and Figure 4—figure supplement 1). Swapping the LCAR domain of chANP32B into huANP32B33
did not prevent the rescue of avian IAV polymerase (huANP32B33LCAR). Introduction of the central
domain of chANP32B into huANP32B (huANP32B33CENT) significantly reduced rescue efficiency and
swapping the LRR domain of chANP32B (huANP32B33LRR) rendered the protein non-functional to
avian IAV polymerase (Figure 4b). By sequential swapping of each LRR repeat, the 5th LRR of
chANP32B was found to be the domain that prevented rescue of avian IAV polymerase (Figure 4b).
The fifth LRR contains five amino acid differences between human and chicken ANP32B, highlighted
on the crystal structure of huANP32A, plus an additional one difference to chANP32A (Figure 4d
and Figure 4—figure supplement 2). Swapping chANP32B’s fifth LRR into chANP32A also pre-
vented rescue of avian IAV polymerase activity in human cells (chANP32ALRR5) (Figure 4c). Introduc-
tion of the single amino acid changes derived from the chANP32B LRR5 sequence into chANP32A
revealed that mutations N129I and D130N significantly reduced the ability of chANP32A to rescue
avian IAV polymerase activity in human cells (Figure 4c). Minigenome assays with co-expressed
chANP32A or chANP32AN129I in aKO chicken fibroblast cells confirmed that the 129I mutation signif-
icantly reduced the ability of chANP32A to support avian-origin (PB2 627E) or human-adapted (PB2
627K) IAV polymerase activity (Figure 4e).
Sequence of amino acids 149–175 of the central domain of chANP32A
are required to support activity of both avian and human-adapted IAV
polymerase
As chANP32A KO PGC-derived fibroblast cells did not support of IAV polymerase despite express-
ing chANP32B, we were able to use these cells to understand in more detail the sequences in
chANP32A required for IAV polymerase activity. The results above showed that the 33 amino acid
insertion, fifth LRR and central domain are important for the ability of chANP32A to support function
of avian IAV polymerase. We performed the minigenome assay in aKO cells with polymerases con-
taining either PB2 627E and 627K with co-expression of further chANP32 mutants including:
chANP32A in which the 27 amino acids in the central domain preceding the 33 amino acid insertion
were scrambled (chANP32Ascr149-175) or chANP32A with the 33 amino acid insertion scrambled
(chANP32Ascr176-208) (Figure 5a). Both mutants were expressed and localised to the nucleus
(Figure 5c and Figure 4—figure supplement 1). The first mutant, chANP32Ascr149-175, did not sup-
port either PB2 627E or 627K polymerase, suggesting the sequence of the central domain is impor-
tant for function of IAV polymerase. The second mutant, chANP32A scr176-208, only supported PB2
627K function, confirming that the sequence of the 33 amino acid insertion, not just the extended
length is required for avian IAV polymerase (PB2 627E) (Figure 5b).
Long et al. eLife 2019;8:e45066. DOI: https://doi.org/10.7554/eLife.45066 7 of 22
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Figure 4. Lack of functional support for IAV polymerase by chicken ANP32B maps to differences in LRR5 domain. (a) Schematic of chicken ANP32A
protein highlighting the different domains and LRR sequences (LRR 1–5). (b) Human 293 T cells were transfected with avian H5N1 50–92 polymerase
(PB2 627E) together with NP, pHOM1-firefly minigenome reporter, Renilla expression control, either Empty vector or FLAG-tagged ANP32 expression
plasmid and incubated at 37˚C for 24 hr. Western blot analysis shown below (FLAG and Vinculin). (c) Minigenome assay in 293 T cells (PB2 627E) with
FLAG-tagged WT or mutant chANP32A expression plasmids with associated western blot (FLAG and PCNA). (d) huANP32A crystal structure (PDB 4 
05) with residues K116, N127, N129, D130 and K137 highlighted using UCSF Chimaera (Pettersen et al., 2004). (e) Minigenome assay of avian H5N1
50–92 polymerase with either PB2 627E or 627K in PGC-derived fibroblast aKO cells, together with co-expressed Empty vector, chANP32A or
chANP32AN129I. Data shown are firefly activity normalised to Renilla, plotted as mean ± SEM (n = 3 biological replicates). One-way ANOVA with Tukey’s
comparison to chANP32A (b and c) or two-way ANOVA with Dunnet’s multiple comparisons to chANP32A (e). ns = not significant, *p<0.05, **p<0.01,
****p<0.0001.
DOI: https://doi.org/10.7554/eLife.45066.011
The following figure supplements are available for figure 4:
Figure supplement 1. Nuclear localisation of exogenously expressed ANP32 proteins in 293 T cells.
DOI: https://doi.org/10.7554/eLife.45066.012
Figure supplement 2. Avian ANP32B proteins share the I129 and N130 residues in LRR5.
DOI: https://doi.org/10.7554/eLife.45066.013
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A single amino acid difference between chANP32B and chANP32A
abrogates binding of chANP32A to IAV polymerase
An interaction between ANP32A and IAV polymerase was demonstrated previously that is depen-
dent on the presence of all three polymerase subunits (Mistry et al. in preparation & Baker et al.,
2018; Domingues and Hale, 2017). To examine the interaction between IAV polymerase and
chANP32 proteins we employed a split luciferase complementation assay as a quantitative measure
of binding (Munier et al., 2013; Cassonnet et al., 2011). The C-terminus of the PB1 subunit of avian
origin IAV polymerase was fused with one half of gaussia luciferase (PB1luc1) and the C-terminus of
chicken ANP32A or B with the second half (chANP32Aluc2 and chANP32Bluc2) (Figure 6a). Reconsti-
tution of PB1luc1, PB2 and PA together with chANP32Aluc2 in human 293 T cells gave a strong Nor-
malised Luciferase Ratio (NLR) (Figure 6—figure supplement 1) with polymerases containing either
PB2 627E or 627K (Figure 6b). Luciferase complementation was significantly less between polymer-
ase and chANP32Bluc2, and even insertion of the 33 amino acids from chANP32A did not restore the
signal (chANP32B33
luc2) (Figure 6b). When chANP32A carried the single N129I mutation (chAN-
P32AN129I
luc2), luciferase complementation was reduced 22-fold for PB2 627E polymerase and 52-
fold forPB2 627K polymerase (Figure 6c and Figure 6—figure supplement 1). These results suggest
Figure 5. Sequence of amino acids 149–175 of the central domain of chANP32A are required to support activity of
both avian and human-adapted IAV polymerase. (a) Schematic of chANP32A showing the sequence of amino
acids in the central domain (149–175 or 33 amino acid insertion (176-208) and the randomly scrambled sequence in
red. (b) Minigenome assay of avian H5N1 50–92 polymerase with either PB2 627E or 627K in PGC-derived
fibroblast aKO cells with co-expressed Empty plasmid or FLAG-tagged WT chANP32A, chANP32Ascr149-175 or
chANP32Ascr176-208 expression plasmids. (c) Western blot analysis of PB2 (627E), lamin B1 and FLAG. Data shown
are firefly activity normalised to Renilla, plotted as mean ± SEM (n = 3 biological replicates). Two-way ANOVA with
Dunnet’s multiple comparisons to chANP32A. ns = not significant, ****p<0.0001.
DOI: https://doi.org/10.7554/eLife.45066.014
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Figure 6. A single amino acid change (N129I) derived from chANP32B disrupts chANP32A support of influenza
polymerase activity by abrogating binding to IAV polymerase. (a) Diagram of the split Gaussia luciferase system,
demonstrating how ANP32 fused to luciferase fragment luc2 may bind to polymerase containing PB1 fused to
luciferase fragment luc1 and complement full luciferase, which then reacts with substrate to generate a
measurable bioluminescent signal. (b) Human 293 T cells were transfected with PB1 fused to luc1 (PB1luc1), PB2
(627E or K), PA and either chANP32A, chANP32B or chANP32B33 fused to luc2 (control wells were transfected with
Figure 6 continued on next page
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that the loss of support of polymerase function by chANP32AN129I was due to a disruption of bind-
ing to IAV polymerase.
ANP32A proteins bind to histones as part of their role in chromatin regulation (Reilly et al.,
2014). To measure if the mutation N129I had any effect on this cellular interaction, we generated
expression plasmids that encoded human histone four with luc1 fused to the C-terminus (H4luc1) and
histone 3.1 with luc2 fused to the C terminus (H3luc2). As expected, H4luc1 and H3luc2 generated a
strong NLR, reflecting their interaction in the nucleosome (Luger et al., 1997). The ability of
chANP32A to bind histone four was not impaired by mutation N129I, suggesting chANP32N129I was
not altered in this cellular role, despite abrogation of its support of IAV polymerase (Figure 6d).
Viral replication is abrogated in chicken cells lacking ANP32A
The data above suggest that chANP32B cannot substitute for chANP32A in support of IAV polymer-
ase in chicken cells. Since chicken cells that completely lack expression of chANP32A show no poly-
merase activity in the minigenome assay, they might be refractory to IAV infection. Multi-cycle
growth kinetics of recombinant influenza A viruses were measured in WT and aKO PGC-derived
fibroblast cells (Figure 7). To ensure robust infection, recombinant viruses were generated carrying
H1N1 vaccine strain PR8 haemagglutinin (HA), neuraminidase (NA) and M genes; this also mitigated
the risks of working with avian influenza viruses with novel antigenicity. Infectious titres of recombi-
nant virus with internal genes of avian H5N1 virus 50–92 were not detected in the chicken cells lack-
ing ANP32A infected at low MOI (Figure 7a). At higher MOI virus titres were significantly reduced
compared to WT chicken cells, almost 325-fold less at 8 hr post infection and 16-fold less by 24 hr
(Figure 7c). Similarly, at low MOI, a recombinant virus with internal genes from the H7N9 virus A/
Anhui/1/2013, had limited virus growth in aKO cells but replicated efficiently in WT fibroblasts
(Figure 7b). At the higher MOI, peak viral titres were 1365-fold less than in WT cells at 8 hr post
infection and 100-fold less by 24 hr (Figure 7d). Since virus growth in aKO cells was observed at the
higher MOI, we sequenced the PB2 gene of virus progeny to determine if this replication was due to
adaptation in PB2. At 24 hr post infection the sequence of the PB2 gene from virus in supernatants
of cells infected at high MOI was determined. Virus recovered from aKO and WT cells was found to
be identical and contained no sequence changes compared with the inoculum, suggesting adapta-
tion in PB2 was not required for the low level of replication seen in the aKO cells. In conclusion, PGC
derived fibroblast cells lacking chANP32A were resilient to IAV replication, particularly at lower mul-
tiplicities of infection.
Discussion
We show that avian origin IAV polymerases rely exclusively on chicken ANP32A family member for
their replication, because they are unable to co-opt chicken ANP32B. We found avian ANP32B pro-
teins formed a separate phylogenetic group from other ANP32Bs (Figure 1 and Figure 1—figure
supplement 1). Synteny demonstrated that an avian ANP32B homologue was present in coelacanth,
amphibians and non-placental mammals as these loci were identical to the ANP32B locus in birds
(Figure 1—figure supplement 2). A functional avian ANP32B homologue has been lost in placental
mammals although a very small part of an ANP32 gene remained in humans (Figure 1—figure sup-
plement 2). Human ANP32C is an intronless gene that is most closely related to ANP32A
Figure 6 continued
all components but with unfused PB1 and luc1 or chANP32 and luc2). (c) As (b) but with either chANP32Aluc2 or
chANP32AN129I
luc2. (d) 293 T cells transfected with either chANP32Aluc2 or chANP32AN129I
luc2 and histone four
fused to luc1 (or with unfused controls) or with H4luc1 and histone three fused to luc2. All data are Normalised
Luciferase Ratio (n = 3 biological replicates) (Figure 6—figure supplement 1). One-way ANOVA (d) or two-way
ANOVA with Dunnet’s multiple comparisons to chANP32A (b and c). ns = not significant, ****p<0.0001.
DOI: https://doi.org/10.7554/eLife.45066.015
The following figure supplement is available for figure 6:
Figure supplement 1. Western blot analysis of split luciferase constructs.
DOI: https://doi.org/10.7554/eLife.45066.016
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(Reilly et al., 2014) and is unrelated to the avian ANP32B clade. There was no evidence found of a
mammalian ANP32B homologue in birds.
Chicken ANP32B could not support influenza polymerase function due to an amino acid differ-
ence in LRR5 at residue 129 that adversely affected the interaction between chANP32B and influenza
polymerase (Figure 6). Other avian ANP32B proteins, including those of duck and turkey, carry iso-
leucine at residue 129 suggesting that our findings may also be applicable to other avian hosts (Fig-
ure 4—figure supplement 2). The replacement of the exposed polar residue, asparagine (N129)
with the hydrophobic isoleucine (I) may have led to the disruption of a key electrostatic interaction
between ANP32A and the virus polymerase complex. In addition to the residue 129I, the central
domain (amino acids 141–175) of chANP32B also contributed to its poor efficiency at rescuing avian
IAV polymerase function in human cells (Figure 4). This, together with the observation that scram-
bling amino acids 149–175 in chANP32A prevented both human-adapted and avian IAV polymerase
function (Figure 4) suggests that LRR5 and the central domain of ANP32A are crucial to IAV poly-
merase function. Our finding that chANP32B is non-functional for IAV polymerase was recently
Figure 7. Viral replication is abrogated in chicken PGC fibroblast cells lacking ANP32A. WT (black lines) or aKO
(red lines) PGC-derived fibroblast cells were infected with recombinant viruses (containing PR8 HA, NA and M
genes and internal genes from either H5N1 50–92 or H7N9 Anhui), at an MOI of either 0.0001 (a,b) or 1.0 (c,d),
incubated at 37˚C in the presence of trypsin, cell supernatants harvested at described time-points and PFU ml 1
measured by plaque assay on MDCK cells. (a) H5N1 50–92 (MOI 0.0001). b. H7N9 Anhui (MOI 0.0001). c. H5N1 50-
 92 (MOI 1.0). d. H7N9 Anhui (MOI 1.0). vRNAs from supernatants 24 hr post infection MOI 1.0 (c and d) were
extracted, PCR amplified and sequenced by Sanger sequencing. Limit of detection by plaque assay shown by
dotted line (10PFU ml 1). n = 3 biological replicates. Multiple t-tests with Holm-Sidak comparison. ns = not
significant, *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001.
DOI: https://doi.org/10.7554/eLife.45066.017
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corroborated by another research group; this preliminary work also found that this phenotype
mapped to residues 129I and 130N of chANP32B (Zhang et al., 2019). The observation that scram-
bling the 33-amino acid insertion prevented avian IAV polymerase rescue (Figure 5) is consistent
with results from by Domingues and Hale and Baker and colleagues which showed that the SUMO
Interaction motif (SIM)-like sequence present in the 33 amino acid insertion (VLSLV), was required for
strong binding to both 627E and 627K polymerase and its deletion or mutation decreased its ability
to support avian IAV polymerase activity in human cells (Baker et al., 2018; Domingues and Hale,
2017). Understanding the domains important to binding and function may help us understand the
mechanism by which ANP32A or B support IAV polymerase which is still not fully elucidated
(Sugiyama et al., 2015).
Chicken cells lacking ANP32A did not support activity of avian or human-adapted IAV polymerase
in minigenome assay (Figure 2). However, at higher MOI, virus replication was observed in aKO
cells, although still significantly lower than in WT PGC cells (Figure 7c&d). This implies some IAV
polymerase function, albeit inefficient, in the absence of chANP32A in the context of virus infection.
Other viral products present during virus infection such as NEP may partly compensate for the block
in replication in cells that lack chANP32A. Indeed NEP expression has been reported to rescue avian
polymerase replication in human cells (Ma¨nz et al., 2012). Nonetheless the significantly reduced
level of virus replication observed in the chicken cells that lack chANP32A in vitro implies that in
vivo, chickens that do not express ANP32A or express altered protein may be resilient to infection
by IAV. It will be pertinent to investigate whether IAV can evolve to replicate in chicken cells that
lack or express a mutated ANP32A although no adaptation of PB2 gene was observed here. The dis-
crepancy between the lack of polymerase activity in the minigenome assay in absence of ANP32A
yet limited replication observed using infectious virus in the same cells may ultimately reveal interest-
ing insights about how ANP32A supports polymerase. The use of the PGC-derived chicken cells to
investigate a host factor essential for virus raises the possibility of generating genome-edited
chicken models resistant or resilient to infection. Chicken PGCs can be efficiently genome-edited to
generate specific haplotypes (Idoko-Akoh et al., 2018). Our novel method of chicken PGC differen-
tiation into fibroblast-like cells enabled robust testing of a defined genotype, and will permit future
investigation of other host genetic factors identified through forward genetic screens and suspected
to play important roles in virus infections (Smith et al., 2015; Wang et al., 2014). We demonstrated
that a mutated chANP32A was able to bind histone 4, suggesting this cellular role may not be
affected by amino acid change at 129. However, there are many roles attributed to ANP32A pro-
teins in the cell, such as embryogenesis, and disruption of these functions may limit the ability to
generate healthy gene-edited animals (Reilly et al., 2014; Reilly et al., 2011).
In summary, we provide evidence that specific domains of ANP32 proteins are important for the
function of IAV polymerases and describe a lack of redundancy in the involvement of ANP32 family
members to support IAV polymerase complex in chicken cells that is determined by the variation in
ANP32 protein sequences. These data may aid in the design of novel small molecule inhibitors that
disrupt the ANP32-polymerase interface and form the basis of a potential pathway for the genera-
tion of influenza virus resilient animals.
Materials and methods
Key resources table
Reagent type
(species) or
resource Designation
Source or
reference Identifiers
Additional
information
Genetic reagent
(G. gallus)
GFP+/Hyline cross Roslin Institute Fertile
heterozygous eggs
for PGC
derivations
(Pettersen et al., 2004)
Primary cells
(G. gallus)
Primordial Germ
Cells (PGCs)
G. gallus
GFP+/Hyline cross,
Roslin Institute
(This study)
Continued on next page
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Continued
Reagent type
(species) or
resource Designation
Source or
reference Identifiers
Additional
information
Cell line
(G. gallus)
DF-1 fibroblasts American Type
Culture Collection
CRL-12203;
RRID:CVCL_0570
Cell line
(C. sapiens)
MDCK American Type
Culture Collection
CCL- 34;
RRID:CVCL_0422
Cell line
(H. sapiens)
293T American Type
Culture Collection
CRL-3216;
RRID:CVCL_0063
Cell line
(H. sapiens)
eHAP1 Horizon Discovery C669
Antibody rabbit polyclonal
a-ANP32A
Sigma-Aldrich AV40203;
RRID:AB_1844874
Dilution
1:500-1:1000
Antibody mouse monoclonal
a-b-actin
Sigma-Aldrich A2228;
RRID:AB_476697
Dilution 1:1000
Antibody mouse monoclonal
a-FLAG
Sigma-Aldrich F1804;
RRID:AB_262044
Dilution 1:1000
(WB), 1:300 (IF)
Antibody mouse monoclonal
a-Lamin B1
Merck MAB5492;
RRID:AB_2085944
Dilution 1:1000
Antibody mouse monoclonal
a-PCNA
Santa Cruz sc-25280,
RRID:AB_628109
Dilution 1:1000
Antibody rabbit polyclonal
a-Histone 3
Abcam AB1791;
RRID:AB_302613
Dilution 1:2000
Antibody rabbit monoclonal
a-vinculin
Abcam AB129002;
RRID:AB_11144129
Dilution 1:1000
Antibody rabbit polyclonal
a-Gaussia Luc
NEB E80235 Dilution 1:2000
Antibody rabbit polyclonal
a-PB1
Invitrogen PA5-34914;
RRID:AB_2552264
Dilution 1:2000
Antibody rabbit polyclonal
a-PB2
GeneTex GTX125926;
RRID:AB_11162999
Dilution 1:2000
Antibody goat polyclonal
anti-rabbit HRP
CST 7074 Dilution 1:2000
Antibody Horse polyclonal
anti-mouse HRP
CST 7076 Dilution 1:2000
Antibody Sheep polyclonal
a-rabbit HRP
Merck AP510P Dilution 1:20000
Antibody goat polyclonal
a-mouse HRP
AbD Serotec STAR117P;
RRID:AB_323839
Dilution 1:10000
Antibody goat polyconal
a-mouse
AlexaFluor-568
Invitrogen A11031;
RRID:AB_144696
Dilution 1:1000
Recombinant
DNA reagent
pGEM-T Easy vector Promega A1360
Recombinant
DNA reagent
pSpCas9(BB) 2A-Puro
PX459 V2.0 vector
Gift from
Dr. Feng Zhang
RRID:Addgene_62988
Recombinant
DNA reagent
pSpCas9n(BB) 2A-GFP
PX461 vecotr
addgene Plasmid 48140;
RRID:Addgene_48140
Recombinant
DNA reagent
pCAGGS vector Belgium Co-ordinated
Collections of
Microorganisms
(BCCM), University
of Ghent, Belgium
Continued on next page
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Continued
Reagent type
(species) or
resource Designation
Source or
reference Identifiers
Additional
information
Recombinant
DNA reagent
H5N1
A/turkey/England/
50-92/1991 polI
plasmids
APHA, Weybridge, UK
Recombinant
DNA reagent
H7N9 Anhui/1/2013
pHW2000 plasmids
Pirbright Institute, UK
Recombinant
DNA reagent
H1N1 A/PR/8/34 (PR8)
polI or pHW2000
plasmids
(Neumann et al., 1999)
Commercial
assay or kit
RNeasy mini kit Qiagen 74106
Commercial
assay or kit
Quick Start Bradford
Protein Assay Kit
Biorad 5000202
Commercial
assay or kit
Dual-luciferase
Reporter assay system
Promega E1910
Commercial
assay or kit
Renilla luciferase kit Promega E2810
Commercial
assay or kit
QIAamp Viral
RNA Mini Kit
Qiagen 52906
Chemical
compound, drug
Lipofectamine 3000 Invitrogen L3000008
Chemical
compound, drug
Lipofectamine 2000 Invitrogen 11668019
Software,
algorithm
Image J ImageJ
(http://imagej.
nih.gov/ij/)
Software,
algorithm
GraphPad Prism GraphPad Prism
(https://
graphpad.com)
version 6
Software,
algorithm
Geneious Geneious
https://www.
geneious.com
R6
Animal use
The GFP+ PGCs used in the experiments were obtained by crossing the Roslin Green (ubiquitous
GFP) line of transgenic chickens with a flock of commercial Hyline layer hens maintained at the Roslin
Institute to produce heterozygous fertile eggs for PGC derivations (Pettersen et al., 2004). Com-
mercial and transgenic chicken lines were maintained and bred under UK Home Office License. All
experiments were performed in accordance with relevant UK Home Office guidelines and regula-
tions. The experimental protocol and studies were reviewed by the Roslin Institute Animal Welfare
and Ethical Review Board (AWERB) Committee. Chickens for egg production were maintained under
the HO code of practice (ISBN 9781474112390).
Plasmid constructs
ANP32A guide RNAs (gRNA) were designed using CHOPCHOP gRNA web tool (http://chopchop.
cbu.uib.no/) (Montague et al., 2014; Labun et al., 2016). gRNA 5’-CGGCCATGGACATGAAGAAA-
3’ targeting ANP32A exon1, and gRNAs: 5’-AGCTGGAAGCAATATGTACT-3’ and 5’-CATTCCCC
TCGCTCCTTCAA-3’ targeting either side of exon 5 (D33 PGC cells) were cloned into pSpCas9(BB) 
2A-Puro (pX459 v2.0; a gift from Dr. Feng Zhang) using Materials and methods described by
previously (Ran et al., 2013a). For DF-1 ANP32B gRNAs, the guides 5’-TTCAGATGATGGGAAGA
TCG-3’ and 5’-GGTTCTCAAAATCTGAAGAG-3’ were cloned into the double ‘nickase’ vectors
pSpCas9n(BB) 2A-GFP (pX461) and pSpCas9n(BB) 2A-Puro (pX462) respectively (Ran et al.,
2013a ; Ran et al., 2013b).
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Gaussia luc1 and luc2 were generated by gene synthesis (GeneArt, ThermoFisher) using the
sequence previously described (Cassonnet et al., 2011). Homo sapiens Histone 4 (NP_003533.1)
and 3.1 (NP_003520.1) were generated gene synthesis (GeneArt, ThermoFisher). Luc1 or luc2 were
added to the C-termini of ANP32, PB1, H4 or H3.1 using the linker sequence, AAAGGGGSGGGGS,
by overlapping PCR. The 33 amino acid insertion was added to huANP32B after residue 173 and to
chANP32B after residue 181 (preserving an acid region before SIM motif [Domingues and Hale,
2017]). The LRR (amino acids 1–149), central domain (amino acids 150–175) or LCAR (amino acids
176–262) from chANP32B were swapped into huANP32B33 to generate chimeric constructs. ANP32
constructs were made by overlapping PCR or by gene synthesis (GeneArt, ThermoFisher) with either
a FLAG tagged fused to the C-terminus with a GSG linker or to mCherry with a GSGGGSGG linker.
Cells and cell culture
Human embryonic kidney (293T) (ATCC) and Madin-Darby canine kidney (MDCK) cells (ATCC) were
maintained in cell culture media (Dulbecco’s modified Eagle’s medium (DMEM; Invitrogen) supple-
mented with 10% fetal calf serum (FCS) (Biosera), 1% non-essential amino acids (NEAA) and with 1%
penicillin-streptomycin (Invitrogen)) and maintained at 37˚C in a 5% CO2 atmosphere. Human
eHAP1 cells (Horizon Discovery) were cultured in Iscove’s Modified Dulbecco’s Medium (IMDM) sup-
plemented with 10% fetal bovine serum (FBS), 1% NEAAs, and 1% penicillin/streptomycin. Chicken
fibroblast (DF-1) (ATCC) cells were maintained in DF-1 cell culture media (DMEM supplemented with
10% FCS, 5% tryptose phosphate broth (Sigma-Aldrich), 1% NEAAs and 1% penicillin-streptomycin
and maintained at 39˚C in a 5% CO2 atmosphere. Cell line authentication: DF-1, eHAP1 and 293 T
cells were authenticated by mRNA analysis confirming the relevant species. All continuous cell lines
were routinely screened for mycoplasma contamination and were mycoplasma free.
PGC, DF-1 and eHAP1 cell line generation
PGCs were derived and cultured in FAOT medium as previously described (Whyte et al., 2015).
PGCs were transiently transfected with 1.5 mg of PX459 V2.0 vector using Lipofectamine 2000 (Invi-
trogen) and treated with puromycin as previously described (Idoko-Akoh et al., 2018). Subse-
quently, single cell cultures of puromycin-resistant cells were established to generate clonal
populations for downstream experiments as previously described in Idoko-Akoh et al. (2018). To
identify an ANP32A D33 PGC cell line, PCR products were directly sequenced using PCR primers to
analyse mutation genotypes of isolated single cell clones. To identify an ANP32A KO PGC cell line,
PCR products were cloned into pGEM-T Easy vector (Promega) and sequenced using T7 promoter
forward primer by Sanger sequencing. DF-1 cells were transfected with the described CRISPR/Cas9
constructs using Lipofectamine 2000 (Invitrogen) and subject to puromycin selection. Single cell
clones were expanded and analysed by PCR of genomic DNA and Sanger sequencing using primers
(5’-TTTTTGCTTACATCTGAGGGC-3’, 5’-CCTCCGCAGTTATCAGGTTAGT-3’) for ANP32A exon1,
(5’-GCTCCCTGGTCTGCTAGTTAT-3’, 5’-GGTCTACGCAACCACACATAC-3’) for ANP32A exon five
and (5’-CCCTTAAGGTGAGCACAGGG-3’, 5’-AACATAGCACCACTCCCAGC-3’) for ANP32B exon2.
eHAP1 dKO cells were generated as described (Staller et al. in review).
Differentiation of PGCs into adherent fibroblast-like cells (PGC derived
fibroblasts)
PGCs were cultured in 500 ml of high calcium FAOT medium containing 1.8 mM CaCl2 in fibronectin-
coated wells (24-well plate) for 48 hr (Figure 3—figure supplement 2) (Whyte et al., 2015). Subse-
quently, PGCs were transferred into PGC fibroblast medium and then refreshed every 48 hr by
removing and replacing with 300 ml of PGC fibroblast cell culture medium. Adherent fibroblast-like
cells were observed within 72 hr. Cells were then refed every two days and split 1:4 every four days.
PGC fibroblast cell cultures were expanded to 85–90% confluency in 24-well plates before using for
transfection, infection or western blot analysis. PGC fibroblast cells were maintained in cell culture
media (Knockout DMEM (10829018, Gibco) with 10% ES grade FBS (16141061, Invitrogen), 1%
chicken serum (Biosera), 0.1% 100xNEAA (Gibco), 0.1% Pyruvate (11360070, Gibco), 0.1% 100xGlu-
tamax (Gibco: 35050–038), 0.5 mg ml 1 ovotransferin (C7786, Sigma)) and 1% penicillin-streptomy-
cin at 37˚C with 5% CO2.
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Influenza A virus infection
Recombinant influenza A PR8 (A/PR/8/34 (H1N1)) 3:5 reassortant virus (PR8 HA, NA and M genes
with PB1, PB2, PA, NP and NS genes from A/Anhui/1/13 (H7N9) was generated by reverse genetics
at The Pirbright Institute, UK. Reverse genetics virus rescue was performed by transfection of Human
Embryonic Kidney (HEK) 293 T cells (ATCC) with eight bi-directional pHW2000 plasmids containing
the appropriate influenza A virus segments and co-culture in MDCK cells (ATCC) with addition of 2
mg ml 1 of TPCK treated Trypsin (Sigma-Aldrich). Rescued viruses were passaged once in embryo-
nated hen’s eggs to generate working stocks. Recombinant PR8 3:5 reassortant 50–92 (A/turkey/
England/50-92/1991 (H5N1) was described previously [Long et al., 2013]).
Virus was diluted in Knockout DMEM and incubated on PGC fibroblast cells for 1 hr at 37˚C (MOI
as indicated in the relevant figure legends) after which inoculum was removed and cells washed with
PBS followed by MES buffer (pH 4, 37˚C) for five mins and a further PBS wash. Infection media
(Knockout DMEM (10829018, Gibco), 0.14% BSA and 1 mg ml 1 TPCK trypsin (Sigma-Aldrich)) wash
added and cells were incubated at 37˚C. To ensure residual virus was removed, a 0 hr time point
was taken. Cell supernatants were harvested and stored at  80˚C. Infectious titres were determined
by plaque assay on MDCK cells.
vRNA extraction from cell supernatants was performed using QIAamp Viral RNA Mini Kit (Qiagen
52906). First strand synthesis was performed using SuperScript IV reverse transcriptase with primer
5’-GCAGGTCAAATATATTCAATATGG-3’. cDNA was amplified using KOD Hot Start DNA polymer-
ase (Merck 71086) using primers 5’-GCAGGTCAAATATATTCAATATGG-3’ and 5’-GGTCG
TTTTTAAACAATTCGAC-3’ and the PCR product was sequenced by Sanger sequencing.
Minigenome assay
Influenza polymerase activity was measured by use of a minigenome reporter which contains the fire-
fly luciferase gene flanked by the non-coding regions of the influenza NS gene segment, transcribed
from a species-specific polI plasmid with a mouse terminator sequence. The human and chicken polI
minigenomes (pHOM1-Firefly and pCOM1-Firefly) are described previously (Moncorge´ et al.,
2013). pCAGGS expression plasmids encoding each polymerase component and NP for 50–92
(H5N1 A/Turkey/England/50–92/91) are described previously (Long et al., 2013). To measure influ-
enza polymerase activity, 293 T cells were transfected in 48-well plates with pCAGGS plasmids
encoding the PB1 (20 ng), PB2 (20 ng), PA (10 ng) and NP (40 ng) proteins, together with 20 ng spe-
cies-specific minigenome reporter, either Empty pCAGGS or pCAGGS expressing ANP32 (50 ng)
and, as an internal control, 10 ng Renilla luciferase expression plasmid (pCAGGS-Renilla), using Lipo-
fectamine 3000 transfection reagent (Invitrogen) according to manufacturers’ instructions. DF-1 and
PGC fibroblast cells were transfected as 293 T cells but with twice the concentration of DNA. Cells
were incubated at 37˚C. 20–24 hr after transfection, cells were lysed with 50 ml of passive lysis buffer
(Promega), and firefly and Renilla luciferase bioluminescence was measured using a Dual-luciferase
system (Promega) with a FLUOstar Omega plate reader (BMG Labtech).
Split luciferase assay
293 T cells were transfected with PB1luc1 (25 ng), either PB2 627E or PB2 627K (25 ng), PA (12.5 ng)
and chANP32Aluc2, chANP32AN129Iluc2, chANP32Bluc2 or chANP32B33
luc2 (12.5 ng). For split lucifer-
ase assays measuring histone interaction, 50 ng of either chANP32Aluc2, chANP32AN129Iluc2, H4luc1
or H3luc2 were transfected into 293 T cells. Control samples assessed the interaction between H4 or
PB1luc1 and an untagged luc2 construct or the appropriate ANP32Aluc2 construct and an untagged
luc1 construct. All other components transfected into control samples remained consistent with
those transfected in with the interacting proteins of interest. 24 hr after transfection, cells were lysed
in 50 ul Renilla lysis buffer (Promega) for one hour at room temperature. Gaussia luciferase activity
was then measured from 10 ul of lysate using the Renilla luciferase kit (Promega) with a FLUOstar
Omega plate reader (BMG Labtech). Normalised luminescence ratios were calculated by dividing
the luminescence measured from the interacting partners by the sum of the interaction measured
from the two controls for each sample (Figure 6—figure supplement 1) as previously described
(Cassonnet et al., 2011).
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Immunoblot analysis
For analysis of PGC derived fibroblasts (Figure 3b), at least 300,000 cells were lysed in 60 ml of 1X
RIPA lysis buffer (sc-24948, Santa Cruz Biotechnology) according to the manufacturer’s instruction.
Protein concentration was determined using the Bradford method with the Quick Start Bradford Pro-
tein Assay Kit (#5000202, BIORAD) according to the manufacturer’s
instruction (Bradford, 1976) Denaturing electrophoresis and western blotting were performed using
the NuPAGE electrophoresis system (Invitrogen) following the manufacturer’s protocol. For all other
Western blots, cells were lysed in lysis buffer (50 mM Tris-HCl pH 7.8 (Sigma Aldrich), 100 mM NaCl,
50 mM KCl and 0.5% Triton X-100 (Sigma Aldrich), supplemented with cOmplete EDTA free Prote-
ase inhibitor cocktail tablet (Roche)) and prepared in Laemmli 2  buffer (Sigma-Aldrich). Cell pro-
teins were resolved by SDS–PAGE using Mini-PROTEAN TGX Precast Gels (Bio-Rad).
Immunoblotting was carried out using the following primary antibodies: rabbit a-ANP32A (Sigma-
Aldrich AV40203), mouse a-b-actin (Sigma-Aldrich A2228), mouse a-FLAG (F1804, Sigma-Aldrich),
mouse a-Lamin B1 (MAB5492, Merck), mouse a-PCNA (sc-25280, Santa Cruz), rabbit a-Histone 3
(AB1791, Abcam), rabbit a-vinculin (AB129002, Abcam), rabbit a-Gaussia Luc (E80235, NEB), rabbit
a-PB1 (PA5-34914, Invitrogen) and rabbit a-PB2 (GTX125926, GeneTex). The following secondary
antibodies were used: goat anti-rabbit HRP (CST #7074), anti-mouse HRP (CST #7076), goat a-
mouse AlexaFluor-568 (A11031, Invitrogen), sheep a-rabbit HRP (AP510P, Merck) and goat a-mouse
HRP (STAR117P, AbD Serotec). Protein bands were visualised by chemiluminescence (ECL +western
blotting substrate, Pierce) using a FUSION-FX imaging system (Vilber Lourmat).
Quantification of chANP32A, B and E mRNA levels
Total RNA from PGC fibroblast and DF-1 cells were extracted using an RNeasy mini kit (Qiagen), fol-
lowing manufacturer’s instructions. During extraction of RNA, RNeasy columns were treated with
RNase-Free DNase (Qiagen). RNA samples were quantified using a Nanodrop Spectrophotometer
(Thermo Scientific). Equal concentrations of RNA were subject to first strand synthesis using Rever-
tAid (Thermo Scientific) with Oligo(dT) (Thermo Scientific). This product was then quantified with
Fast SYBR Green Master Mix (Thermo Scientific) using the following sequence-specific primer pairs:
RS17, (5’-ACACCCGTCTGGGCAACGACT-3’ and 5’-CCCGCTGGATGCGCTTCATCA-3’), RPL30 (5’-
CCAACAACTGTCCTGCTTT-3’ and 5’-GAGTCACCTGGGTCAATAA-3’), chANP32A (50-G
TTTGCAACTGAGGCTAAGC-30 and 5’-CAACTGTAGGTCATACGAAGGC-3’), chANP32B (50- GG
TGGCCTTGAAGTTCTAGC-30, and 5’-ATGAGCATCGTCACCTCGC-3’), chANP32E (5’- GAAC
TAGAGTTTCTTAGCATGG-3’ and 5’- TCTCTCTGCAAGGACCTCCAG-3’). Real-time quantitative
PCR analysis was performed (Applied Biosystems ViiA 7 Real-Time PCR System).
Safety/biosecurity
All work with infectious agents was conducted in biosafety level two facilities, approved by the
Health and Safety Executive of the UK and in accordance with local rules, at Imperial College Lon-
don, UK.
Bioinformatics
ANP32 sequences were downloaded from Ensembl (Gene Trees ENSGT00940000153254 and
ENSGT00940000154305.) Amino acid sequences were aligned using MUSCLE (Edgar, 2004) and
the maximum likelihood tree was constructed using RAxML-HPC2
v.8.2.10 (Stamatakis, 2014) (GTRGAMMA model, 100 bootstraps) on XSEDE run on
CIPRES (Miller et al., 2010). Mapmodulin from Drosophila melanogaster was used as an outgroup.
Statistical analysis was performed using GraphPad Prism v.7. Sequencing data was analysed using
Geneious Sorfware R6. Image analysis was done using Image J and Microsoft Office 2016.
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